Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid in Spinal Fusion Surgery
NCT03425799Phase 3Terminated
- Sponsor
- Exela Pharma Sciences
- Start
- Oct 2018
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tranexamic acid, sponsored by Exela Pharma Sciences. Started Oct 2018; status: terminated.
02
Drugs
tranexamic acid
Beyond the preview
Go deeper on NCT03425799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03425799.